We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
-17.94%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$37.2B
AUM Growth
-$12.8B
(-26%)
Cap. Flow
-$1.76B
Cap. Flow
% of AUM
-4.73%
Top 10 Holdings %
Top 10 Hldgs %
50.93%
Holding
153
New
8
Increased
51
Reduced
61
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$387M |
| 2 |
Meta Platforms (Facebook)
META
|
+$341M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$280M |
| 4 |
Baidu
BIDU
|
+$129M |
| 5 |
Twilio
TWLO
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sony
SONY
|
+$500M |
| 2 |
RTX Corp
RTX
|
+$240M |
| 3 |
Gartner
IT
|
+$199M |
| 4 |
Alibaba
BABA
|
+$155M |
| 5 |
American Express
AXP
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Consumer Discretionary | 7.45% |
| 3 | Communication Services | 5.61% |
| 4 | Financials | 5.39% |
| 5 | Real Estate | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Rhythm Pharmaceuticals
RYTM
$7.96B
| $6.22M | 0.02% |
+1,500,000
| New | +$8.21M |
|
127
Stem
STEM
$52.7M
| $5.49M | 0.01% |
38,340
-662
| -2% | -$110K |
|
128
Caribou Biosciences
CRBU
$164M
| $4.74M | 0.01% |
873,549
-350,000
| -29% | -$2.68M |
|
|
AVYA
129
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $4.74M | 0.01% |
2,115,648
-2,445,393
| -54% | -$17.5M |
|
|
130
Sony
SONY
$138B
| $4.5M | 0.01% |
275,000
-28,229,500
| -99% | -$500M |
|
131
CoStar Group
CSGP
$12.3B
| $4.23M | 0.01% |
70,000
-913,459
| -93% | -$55.3M |
|
|
ATVI
132
DELISTED
Activision Blizzard
ATVI
| $1.99M | 0.01% |
25,495
| – | – |
|
|
MREO
133
Mereo BioPharma
MREO
$47.3M
| $1.94M | 0.01% |
1,735,600
-200,000
| -10% | -$155K |
|
134
Alector
ALEC
$199M
| $1.02M | ﹤0.01% |
+100,000
| New | +$997K |
|
135
Take-Two Interactive
TTWO
$46.1B
| $709K | ﹤0.01% |
5,787
| – | – |
|
136
PUT
Apple
AAPL
$4.57T
| – | – |
-1,000,000
| Closed | -$175M |
|
137
Coinbase
COIN
$40.5B
| – | – |
-429,865
| Closed | -$40.9M |
|
138
Dollar General
DG
$27.9B
| – | – |
-398,807
| Closed | -$88.8M |
|
139
CALL
Walt Disney
DIS
$181B
| – | – |
-1,000,000
| Closed | -$137M |
|
140
Equifax
EFX
$21.4B
| – | – |
-590,133
| Closed | -$140M |
|
|
141
Gartner
IT
$11.7B
| – | – |
-669,268
| Closed | -$199M |
|
142
CALL
NVIDIA
NVDA
$5.42T
| – | – |
-16,000,000
| Closed | -$437M |
|
|
143
RTX Corp
RTX
$301B
| – | – |
-2,420,849
| Closed | -$240M |
|
144
CALL
Atlassian
TEAM
$37.8B
| – | – |
-304,800
| Closed | -$89.6M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Alkeon Capital Management held 153 positions worth $37.2B, down 26% from $49.9B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Alkeon Capital Management withdrew a net $1.76B in Q2 2022, closing 9 positions and reducing 61 holdings. Its most notable exit was RTX Corp, an estimated $240M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Alkeon Capital Management opened a new position in ASML worth $330M.
- Alkeon Capital Management's largest Q2 2022 buy was ASML: 693,681 shares worth $330M.
- Alkeon Capital Management added most to Meta Platforms (Facebook) in Q2 2022, an estimated $341M increase.
- Alkeon Capital Management's biggest Q2 2022 reduction was Sony, cutting an estimated $500M.
- Alkeon Capital Management fully exited RTX Corp in Q2 2022, selling an estimated $240M.
- Alkeon Capital Management's ten largest holdings make up 51% of its $37.2B portfolio in Q2 2022.
- Alkeon Capital Management opened 8 new positions and closed 9 in Q2 2022.
- Alkeon Capital Management's portfolio value fell 26% quarter-over-quarter to $37.2B.
Based on Alkeon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.